• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

    44.09 +7.39 (+20.14%)
    Streaming Delayed Price Updated: 10:49 AM EDT, Jul 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,467,413
    Open 37.94
    Bid (Size) 43.92 (100)
    Ask (Size) 44.16 (200)
    Prev. Close 36.70
    Today's Range 37.50 - 44.19
    52wk Range 9.100 - 37.58
    Shares Outstanding 21,051,195
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement ↗
    Forte Biosciences (NASDAQ:FBRX) said FB102 showed statistically significant improvement in a small placebo-controlled vitiligo study, with Chief Executive Officer Paul Wagner highlighting continued... 
    Via MarketBeat
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill

    Performance

    YTD
    +86.7%
    +86.7%
    1 Month
    +159.4%
    +159.4%
    3 Month
    +30.1%
    +30.1%
    6 Month
    +82.3%
    +82.3%
    1 Year
    +253.3%
    +253.3%

    More News

    Read More
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Forte Biosciences Announces Pricing of $150 Million Public Offering
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences Announces Proposed Public Offering
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces 2025 Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences Tops Q2 Loss Forecasts ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Forte Biosciences, Inc. Announces Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Forte Biosciences, Inc. - Common Stock publicly traded?
    Yes, Forte Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Forte Biosciences, Inc. - Common Stock trade on?
    Forte Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Forte Biosciences, Inc. - Common Stock?
    The ticker symbol for Forte Biosciences, Inc. - Common Stock is FBRX on the Nasdaq Stock Market
    What is the current price of Forte Biosciences, Inc. - Common Stock?
    The current price of Forte Biosciences, Inc. - Common Stock is 44.09
    When was Forte Biosciences, Inc. - Common Stock last traded?
    The last trade of Forte Biosciences, Inc. - Common Stock was at 07/10/26 10:49 AM ET
    What is the market capitalization of Forte Biosciences, Inc. - Common Stock?
    The market capitalization of Forte Biosciences, Inc. - Common Stock is 928.15M
    How many shares of Forte Biosciences, Inc. - Common Stock are outstanding?
    Forte Biosciences, Inc. - Common Stock has 928M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.